High-temperature formulations provide robust material performance at elevated temperatures in excess of 300°F (150°C).

Bradley C.

Shanghai, China (c) 54. c) There are two manufacturing plants located in Shanghai, China. HIGHLIGHTS from 2023: Key Markets Key Customer Challenges • Preser ving key natural resources • Increasing healthcare regulations • Enabling connectivity & alternative energy • Increasing regulator y compliance Avient Solutions & Services • Specialty formulations, colorants and additives to meet medical device regulations • Specialty optical fibers for telecommunications • Advanced composite and fiber solutions for alternative energy infrastructure • Regulator y compliance expertise PRESERVE SUPPORTS SUSTAINABLE INFRASTRUCTURE Infrastructure Retrofit for Hydrogen Power Fiber-Line™ Engineered Fibers LEARN MORE Healthcare Energy Consumer NON-PTFE FORMULATIONS Non-Fluorinated Polymers LubriOne™ Internally Lubricated Formulations LEARN MORE UP TO 100% BIO-BASED CARRIER Medical Devices Mevopur™ Bio-Based Polymer Solutions LEARN MORE 75% Spin Dyed Textile Yarn Renol™ Spin Dying Colorants LEARN MORE LESS WATER UP TO 40% BIO-DERIVED Pharmaceutical Tubing Versaflex™ HC BIO BT218 TPE LEARN MORE ENABLE ALTERNATIVE ENERGY SOURCES Photovoltaic Wire & Cable ECCOH™ XL 8148 Cross-Linkable Solutions LEARN MORE LEARN MORE Avient Sustainability HOME | Contents | Message from the CEO | About Us | People | Products | Planet | Per formance | Metrics | Index Sustainability Report | 2023 44Sustainability Report | 2023 44 https://www.avient.com/news/avient-showcase-world-s-strongest-fiber-and-high-performance-engineered-fibers-techtextil-2024 https://www.avient.com/sites/default/files/2024-04/LubriOne%20Internally%20Lubricated%20Formulations%20PTFE%20Free%20Series%20Product%20Bulletin.pdf https://www.avient.com/products/polymer-colorants/healthcare-colorants/mevopur-healthcare-bio-based-polymer-solutions https://www.avient.com/products/polymer-colorants/fiber-colorants/renol-fiber-colorants https://www.avient.com/sites/default/files/2023-07/Versaflex%20HC%20_%20Versaflex%20HC%20BIO%20-%20BT%20Series%20Product%20Overview.pdf https://www.avient.com/idea/understanding-needs-and-challenges-photovoltaic-cable https://www.avient.com/company/sustainability/sustainable-solutions-portfolio Product Stewardship Management Approach Protecting associates, customers and the environment by providing safe products is a priority for Avient.

Shanghai, China (c) 54. c) There are two manufacturing plants located in Shanghai, China. HIGHLIGHTS from 2023: Key Markets Key Customer Challenges • Preser ving key natural resources • Increasing healthcare regulations • Enabling connectivity & alternative energy • Increasing regulator y compliance Avient Solutions & Services • Specialty formulations, colorants and additives to meet medical device regulations • Specialty optical fibers for telecommunications • Advanced composite and fiber solutions for alternative energy infrastructure • Regulator y compliance expertise PRESERVE SUPPORTS SUSTAINABLE INFRASTRUCTURE Infrastructure Retrofit for Hydrogen Power Fiber-Line™ Engineered Fibers LEARN MORE Healthcare Energy Consumer NON-PTFE FORMULATIONS Non-Fluorinated Polymers LubriOne™ Internally Lubricated Formulations LEARN MORE UP TO 100% BIO-BASED CARRIER Medical Devices Mevopur™ Bio-Based Polymer Solutions LEARN MORE 75% Spin Dyed Textile Yarn Renol™ Spin Dying Colorants LEARN MORE LESS WATER UP TO 40% BIO-DERIVED Pharmaceutical Tubing Versaflex™ HC BIO BT218 TPE LEARN MORE ENABLE ALTERNATIVE ENERGY SOURCES Photovoltaic Wire & Cable ECCOH™ XL 8148 Cross-Linkable Solutions LEARN MORE LEARN MORE Avient Sustainability HOME | Contents | Message from the CEO | About Us | People | Products | Planet | Per formance | Metrics | Index Sustainability Report | 2023 44Sustainability Report | 2023 44 https://www.avient.com/news/avient-showcase-world-s-strongest-fiber-and-high-performance-engineered-fibers-techtextil-2024 https://www.avient.com/sites/default/files/2024-04/LubriOne%20Internally%20Lubricated%20Formulations%20PTFE%20Free%20Series%20Product%20Bulletin.pdf https://www.avient.com/products/polymer-colorants/healthcare-colorants/mevopur-healthcare-bio-based-polymer-solutions https://www.avient.com/products/polymer-colorants/fiber-colorants/renol-fiber-colorants https://www.avient.com/sites/default/files/2023-07/Versaflex%20HC%20_%20Versaflex%20HC%20BIO%20-%20BT%20Series%20Product%20Overview.pdf https://www.avient.com/idea/understanding-needs-and-challenges-photovoltaic-cable https://www.avient.com/company/sustainability/sustainable-solutions-portfolio Product Stewardship Management Approach Protecting associates, customers and the environment by providing safe products is a priority for Avient.

c. Contact Avient’s Legal Department at your first opportunity and document the incident. 9 HOME | TOC Updated: February 2021 North America Global Headquarters Avon Lake, United States 33587 Walker Road Avon Lake, OH, United States 44012 Toll Free: +1 866 765 9663 Phone: +1 440 930 1000 Fax: +440 930 3064 Asia Pacific Regional Headquarters Shanghai, China 2F, Block C 200 Jinsu Road Pudong, 201206 Shanghai, China Telephone: +86 (0) 21 6028 4888 Fax: +86 (0) 21 6028 4999 South America Regional Headquarters Sao Paulo, Brazil Av.

Tap water was put in a beaker, the top of the beaker was covered with a sample of the test film, and the beaker was put in a refrigerator at 4°C (39°F).

a) 米国食品医薬品局（FDA）または国際標準化機構（ISO）により「インプラント」機器として分類される医療機器、または米国薬局方（USP）または ISO 規格で定義される「パーマネント」 機器、または (b)EU指令90/385/EECの改正で定義された能動埋込型医療機器、または (c)EU指令93/42/EECの改正で定義された「長期」使用のための医療機器。

PolyOne Corporation Page 4 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • 20 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Continue specialty transformation • Goal of $2.50 adjusted EPS by 2015, three times the EPS generated in 2011 of $0.82 • Drive double digit operating income and adjusted EPS growth PolyOne Corporation Page 5 Building & Construction 13% Industrial 12% Transportation 18% Wire & Cable 9% Packaging 16% Consumer 10% HealthCare 11% Appliance 6% Electronics & Electrical 5% 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion PolyOne At A Glance United States 67% Europe 14% Canada 7% Asia 6% Latin America 6% Specialty 54% PP&S 18% Distribution 28% $13 $31 $46 $46 $92 $96 $122 $195 $0 $50 $100 $150 $200 2006 2007 2008 2009 2010 2011 2012 2013 Specialty Operating Income PolyOne Corporation Page 6 Old PolyOne *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 65% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2014 YTD 2015 % o f O p e ra ti n g I n c o m e * JV's Performance Products & Solutions Distribution Specialty 65-75% Specialty OI $5M $46M $87M $195M $191M Target Mix Shift Highlights Specialty Transformation Transformation 2015 Target PolyOne Corporation Page 7 Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence PolyOne Corporation Page 8 Strategy and Execution Drive Results $0.12 $0.27 $0.21 $0.13 $0.68 $0.82 $1.00 $1.31 '06 '07 '08 '09 '10 '11 '12 '13 ‘06-‘13 EPS CAGR = 41% EPS Share Price vs.

PolyOne Corporation Page 4 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • 19 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Continue specialty transformation • Goal of $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth PolyOne Corporation Page 5 Building & Construction 13% Industrial 12% Transportation 18% Wire & Cable 9% Packaging 16% Consumer 10% HealthCare 11% Appliance 6% Electronics & Electrical 5% 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion PolyOne At A Glance United States 67% Europe 14% Canada 7% Asia 6% Latin America 6% Specialty 54% PP&S 18% Distribution 28% $13 $31 $46 $46 $92 $96 $122 $195 $0 $50 $100 $150 $200 2006 2007 2008 2009 2010 2011 2012 2013 Specialty Operating Income PolyOne Corporation Page 6 Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 66% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2014 YTD 2015 % o f O p e ra ti n g I n c o m e * JV's Performance Products & Solutions Distribution Specialty 65-75% Specialty OI $5M $46M $87M $195M $129M Target Mix Shift Highlights Specialty Transformation 2015 Target PolyOne Corporation Page 7 Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence PolyOne Corporation Page 8 Strategy and Execution Drive Results $0.12 $0.27 $0.21 $0.13 $0.68 $0.82 $1.00 $1.31 '06 '07 '08 '09 '10 '11 '12 '13 ‘06-‘13 EPS CAGR = 41% EPS Share Price vs.

PolyOne Corporation Page 4 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • 19 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Continue specialty transformation • Goal of $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth PolyOne Corporation Page 5 Building & Construction 13% Industrial 12% Transportation 18% Wire & Cable 9% Packaging 16% Consumer 10% HealthCare 11% Appliance 6% Electronics & Electrical 5% 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion PolyOne At A Glance United States 67% Europe 14% Canada 7% Asia 6% Latin America 6% Specialty 54% PP&S 18% Distribution 28% $13 $31 $46 $46 $92 $96 $122 $195 $0 $50 $100 $150 $200 2006 2007 2008 2009 2010 2011 2012 2013 Specialty Operating Income PolyOne Corporation Page 6 Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 66% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2014 YTD 2015 % o f O p e ra ti n g I n c o m e * JV's Performance Products & Solutions Distribution Specialty 65-75% Specialty OI $5M $46M $87M $195M $129M Target Mix Shift Highlights Specialty Transformation 2015 Target PolyOne Corporation Page 7 Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence PolyOne Corporation Page 8 Strategy and Execution Drive Results $0.12 $0.27 $0.21 $0.13 $0.68 $0.82 $1.00 $1.31 '06 '07 '08 '09 '10 '11 '12 '13 ‘06-‘13 EPS CAGR = 41% EPS Share Price vs.